Randomized, Global, Phase III Study Of Tislelizumab (Tis) + Chemotherapy (Chemo) Vs Placebo (Pbo) + Chemo As First-Line (1L) Treatment For Advanced/Metastatic Esophageal Squamous Cell Carcinoma (Escc): Rationale-306 Update
Tislelizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Randomized, Global, Phase III Study Of Tislelizumab (Tis) + Chemotherapy (Chemo) Vs Placebo (Pbo) + Chemo As First-Line (1L) Treatment For Advanced/Metastatic Esophageal Squamous Cell Carcinoma (Escc): Rationale-306 Update ### Output: Tislelizumab